Wednesday, September 27, 2017 2:19:53 PM
My thinking is they see the potential us long term holders see on the drug pipeline.
Right or wrong that is my thinking. They didn't sell off when we took the hit and kept on adding shares.
A high number can be positive for the price if and when short decide to cover and can't.
We have a break out at 18.47. New target is now 19.50.
There can or can't be less volatility if they hang onto their shares making the newbies pay a higher price to acquire shares. FDA approval of the 40MG might just be the catalyst when there might be few shares available to buy.
The fact they have chosen to put us at high ownership. i.e.. only 115 other companies with this high ownership says something about their opinion going forward. Just my opinion.
Time will tell.
Boing X 2
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM